Faculty profile

Qing-Bin Lu

ResearcherUniversity of Waterloo

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Waterloo directory, so their courses may be missing. Find their university profile.

Qing-Bin Lu

Researcher

Health Sciences

University of Waterloo

Waterloo, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
3 publications in the last five years, latest in 2026.
Principal investigator on 7 research grants (4 NSERC, 3 CIHR), most recently in 2019.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Biophysics Cancer Therapy Chemotherapy Medical Physics Radiotherapy Novel Combination Therapy

Latest papers

Reply to Godin-Beekmann et al.: Quantitative agreement between the CRE theory and spatiotemporal ozone observations is well founded.
Proceedings of the National Academy of Sciences of the United States of America · 2026 · first author
Cosmic ray-driven electron-induced reaction theory quantifies spatiotemporal variations in lower-stratospheric ozone and temperature.
Proceedings of the National Academy of Sciences of the United States of America · 2025 · first author
Formulation of the cosmic ray-driven electron-induced reaction mechanism for quantitative understanding of global ozone depletion.
Proceedings of the National Academy of Sciences of the United States of America · 2023 · first author

All 20 publications

Latest funding

Development of Novel Non-Platinum-Based Antitumor Agents for Natural Targeted Chemotherapy and Radiotherapy of Cervical, Lung and Ovarian Cancers
CIHR · 2019 · Nominated PI
$910,350
Development of novel combination therapy of cisplatin with a molecular promoter to treat multiple cancers
CIHR · 2018 · Nominated PI
$99,990
Observations and Applications of Dissociative Electron Transfer Reactions in Selected Molecular Systems
NSERC · 2017 · Principal investigator
$168,000

All 9 grants and awards

20 publications.

Reply to Godin-Beekmann et al.: Quantitative agreement between the CRE theory and spatiotemporal ozone observations is well founded.

Lu QB

Proceedings of the National Academy of Sciences of the United States of America2026First author

DOI: 10.1073/pnas.2537183123 PMID: 41941634

Cosmic ray-driven electron-induced reaction theory quantifies spatiotemporal variations in lower-stratospheric ozone and temperature.

Lu QB

Proceedings of the National Academy of Sciences of the United States of America2025First author

DOI: 10.1073/pnas.2506469122 PMID: 40591605

Formulation of the cosmic ray-driven electron-induced reaction mechanism for quantitative understanding of global ozone depletion.

Lu QB

Proceedings of the National Academy of Sciences of the United States of America2023First author

DOI: 10.1073/pnas.2303048120 PMID: 37364123

New combination chemotherapy of cisplatin with an electron-donating compound for treatment of multiple cancers.

Zhang Q, Lu QB

Scientific reports2021Senior author

DOI: 10.1038/s41598-020-80876-z PMID: 33436996

Reaction Cycles of Halogen Species in the Immune Defense: Implications for Human Health and Diseases and the Pathology and Treatment of COVID-19.

Lu QB

Cells2020First author

DOI: 10.3390/cells9061461 PMID: 32545714

Design, synthesis and photocytotoxicity of upconversion nanoparticles: Potential applications for near-infrared photodynamic and photothermal therapy.

Hu Y, Honek JF, Wilson BC, Lu QB

Journal of biophotonics2019Senior author

DOI: 10.1002/jbio.201900129 PMID: 31298812

Preclinical Evaluation of 1,2-Diamino-4,5-Dibromobenzene in Genetically Engineered Mouse Models of Pancreatic Cancer.

Goetze RG, Buchholz SM, Ou N, Zhang Q, Patil S, Schirmer M, Singh SK, Ellenrieder V, Hessmann E, Lu QB, Neesse A

Cells2019

DOI: 10.3390/cells8060563 PMID: 31181844

Electrochemical methods for probing DNA damage mechanisms and designing cisplatin-based combination chemotherapy.

Li Z, Zilberman Y, Lu QB, Tang XS

BioTechniques2019

DOI: 10.2144/btn-2018-0106 PMID: 30869547

Combination of Near Infrared Light-Activated Photodynamic Therapy Mediated by Indocyanine Green with Etoposide to Treat Non-Small-Cell Lung Cancer.

Luo T, Zhang Q, Lu QB

Cancers2017Senior author

DOI: 10.3390/cancers9060063 PMID: 28587258

Squarate-based carbocyclic nucleosides: Syntheses, computational analyses and anticancer/antiviral evaluation.

Lu M, Lu QB, Honek JF

Bioorganic & medicinal chemistry letters2017

DOI: 10.1016/j.bmcl.2016.11.058 PMID: 27913181

Development of Novel Non-Platinum-Based Antitumor Agents for Natural Targeted Chemotherapy and Radiotherapy of Cervical, Lung and Ovarian Cancers

Nominated PICIHR2019Project Grant

Principal investigators: Lu, Qing-Bin

Keywords: Biophysics; Cancer Therapy; Chemotherapy; Medical Physics; Radiotherapy

$910,350

Development of novel combination therapy of cisplatin with a molecular promoter to treat multiple cancers

Nominated PICIHR2018Operating Grant: CCS Innovation Grants

Principal investigators: Lu, Qing-Bin

Keywords: Novel Combination Therapy

$99,990

Observations and Applications of Dissociative Electron Transfer Reactions in Selected Molecular Systems

Principal investigatorNSERC2017Discovery Grants Program - Individual

Principal investigators: Lu, QingBin

$168,000

Upgrade of U of Waterloo's primary confocal microscope with state-of-the-art correlative microscopy for co-applicants in 11 departments

Co-investigatorNSERC2015Research Tools and Instruments - Category 1 (<$150,000)

Principal investigators: Spafford, David

$144,912

Cell sorter for university facility

Co-investigatorNSERC2014Research Tools and Instruments - Category 1 (<$150,000)

Principal investigators: Dixon, Brian

$150,000

Ultrafast electron - transfer reactions in radiation chemistry and radiation biology

Principal investigatorNSERC2011Discovery Grants Program - Individual

Principal investigators: Lu, QingBin

$225,000

Molecular-Mechanism-Based Target Identification and Drug Discovery for Radiotherapy of Cancer

Nominated PICIHR2009Operating Grant

Principal investigators: Lu, Qing-Bin

Keywords: Anticancer Drugs; Biophysics; Cancer Radiotherapy; Medical Physics; Radiation Biology; Ultrafast Time-Resolved Laser Spectroscopy

$662,867

Application of time-resolved femtosecond laser spectroscopy to biological, medical and environmental studies

Principal investigatorNSERC2006Discovery Grants Program - Individual

Principal investigators: Lu, QingBin

$113,620

A surface science analysis sytem for environmental studies

Principal investigatorNSERC2004Research Tools and Instruments - Category 1 (<$150,000)

Principal investigators: Lu, QingBin

$149,866

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2019

Subject: Prospective PhD student: Biophysics Dear Professor Lu, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Reply to Godin-Beekmann et al.: Quantitative agreement between the CRE theory and spatiotemporal ozone observations is well founded." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Development of Novel Non-Platinum-Based Antitumor Agents for Natural Targeted Chemotherapy and Radiotherapy of Cervical, Lung and Ovarian Cancers" (2019), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction